1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:Patient characteristics and clinical information before emergency carotid artery stent placement
Case No./Sex/Age (y) Type of Stroke Clinical Symptoms NIHSS Score Treatment Onset to Procedure (hrs) 1/F/83 SO Deep coma, CD, QP 28 Aspirin, ticlopidine 2 2/M/65 SO Somnolence, MA, FP, HP 9 Aspirin 10 3/M/69 SO Coma, CD, HP 19 None 24 4/M/60 SO Coma, HP 18 None 8 5/M/68 SO Somnolence, HP 7 Aspirin 12 6/M/28 SO Somnolence, FP, HP 13 None 2 7/M/78 SO Stupor, AG, CD, FP, HP 15 None 17 8/M/83 SO Somnolence, FP, HP 12 Aspirin 18 9/M/66 SO Somnolence, FP, HP 11 None 6 10/F/86 PR Somnolence, SA, HP 12 Heparin 125 11/M/69 PR Somnolence, AG, HP 11 Heparin, ozagrel sodium 72 12/M/68 PR AG, HP 5 Heparin, ozagrel sodium 149 13/F/74 PR Stupor, AG, FP, HP 15 Argatroban 54 14/F/69 PR Somnolence, FP, HP 7 Argatroban, aspirin 120 15/M/82 PR Coma, CD, HP 24 Heparin 26 16/M/62 PR FP, HP 5 Heparin, aspirin 120 17/M/79 PR FP, HP 5 Argatroban, ticlopidine 168
Note.—SO indicates sudden onset of severe stroke; PR, progressing stroke; CD, conjugate deviation of the eyes; QP, quadriparesis; MA, motor-dominant aphasia; FP, facial palsy; HP, hemiplegia or hemiparesis; AG, agnosia; SA, sensory-dominant aphasia.